Pharmacoeconomic Analyses and Modeling

Dixon Thomas; Mickael Hiligsmann; Denny John; Ola Ghaleb Al Ahdab; Hong Li

doi:10.1016/B978-0-12-814276-9.00018-0

Pharmacoeconomic Analyses and Modeling

Dixon Thomas, Mickael Hiligsmann, Denny John, Ola Ghaleb Al Ahdab, Hong Li

Research output: Chapter in Book/Report/Conference proceeding › Chapter › Academic

Abstract

Pharmacoeconomic analyses are increasingly used to help decision-makers assess the value of health interventions. This value assessment promotes the effective and affordable use of healthcare resources. Different frameworks used in pharmacoeconomic analyses, with a focus on common modeling methods, are discussed. The following pharmacoeconomic analyses are compared and contrasted: cost-of-illness analysis (COI), budget-impact analysis (BIA), cost-comparison analysis, cost-minimization analysis (CMA), cost-effectiveness analysis (CEA), cost-utility analysis (CUA), cost-consequence analysis (CCA), and cost-benefit analysis (CBA). The commonly used modeling methods, including decision trees and Markov models, are compared.

Original language	English
Title of host publication	Clinical Pharmacy Education, Practice and Research
Subtitle of host publication	Clinical Pharmacy, Drug Information, Pharmacovigilance, Pharmacoeconomics and Clinical Research
Editors	Dixon Thomas
Publisher	Elsevier
Chapter	18
Pages	261-275
Number of pages	15
ISBN (Electronic)	9780128142769
ISBN (Print)	9780128142776
DOIs	https://doi.org/10.1016/B978-0-12-814276-9.00018-0
Publication status	Published - 2019

Keywords

Affordability
Cost-effectiveness
Evaluation
Pharmacoeconomic analysis

Access to Document

10.1016/B978-0-12-814276-9.00018-0

Cite this

@inbook{d66a696a0157436586d17d90b7236736,

title = "Pharmacoeconomic Analyses and Modeling",

abstract = "Pharmacoeconomic analyses are increasingly used to help decision-makers assess the value of health interventions. This value assessment promotes the effective and affordable use of healthcare resources. Different frameworks used in pharmacoeconomic analyses, with a focus on common modeling methods, are discussed. The following pharmacoeconomic analyses are compared and contrasted: cost-of-illness analysis (COI), budget-impact analysis (BIA), cost-comparison analysis, cost-minimization analysis (CMA), cost-effectiveness analysis (CEA), cost-utility analysis (CUA), cost-consequence analysis (CCA), and cost-benefit analysis (CBA). The commonly used modeling methods, including decision trees and Markov models, are compared.",

keywords = "Affordability, Cost-effectiveness, Evaluation, Pharmacoeconomic analysis",

author = "Dixon Thomas and Mickael Hiligsmann and Denny John and {Al Ahdab}, {Ola Ghaleb} and Hong Li",

year = "2019",

doi = "10.1016/B978-0-12-814276-9.00018-0",

language = "English",

isbn = "9780128142776",

pages = "261--275",

editor = "Thomas, {Dixon }",

booktitle = "Clinical Pharmacy Education, Practice and Research",

publisher = "Elsevier",

address = "United States",

}

Pharmacoeconomic Analyses and Modeling. / Thomas, Dixon; Hiligsmann, Mickael; John, Denny et al.
Clinical Pharmacy Education, Practice and Research: Clinical Pharmacy, Drug Information, Pharmacovigilance, Pharmacoeconomics and Clinical Research. ed. / Dixon Thomas. Elsevier, 2019. p. 261-275.

Research output: Chapter in Book/Report/Conference proceeding › Chapter › Academic

TY - CHAP

T1 - Pharmacoeconomic Analyses and Modeling

AU - Thomas, Dixon

AU - Hiligsmann, Mickael

AU - John, Denny

AU - Al Ahdab, Ola Ghaleb

AU - Li, Hong

PY - 2019

Y1 - 2019

N2 - Pharmacoeconomic analyses are increasingly used to help decision-makers assess the value of health interventions. This value assessment promotes the effective and affordable use of healthcare resources. Different frameworks used in pharmacoeconomic analyses, with a focus on common modeling methods, are discussed. The following pharmacoeconomic analyses are compared and contrasted: cost-of-illness analysis (COI), budget-impact analysis (BIA), cost-comparison analysis, cost-minimization analysis (CMA), cost-effectiveness analysis (CEA), cost-utility analysis (CUA), cost-consequence analysis (CCA), and cost-benefit analysis (CBA). The commonly used modeling methods, including decision trees and Markov models, are compared.

AB - Pharmacoeconomic analyses are increasingly used to help decision-makers assess the value of health interventions. This value assessment promotes the effective and affordable use of healthcare resources. Different frameworks used in pharmacoeconomic analyses, with a focus on common modeling methods, are discussed. The following pharmacoeconomic analyses are compared and contrasted: cost-of-illness analysis (COI), budget-impact analysis (BIA), cost-comparison analysis, cost-minimization analysis (CMA), cost-effectiveness analysis (CEA), cost-utility analysis (CUA), cost-consequence analysis (CCA), and cost-benefit analysis (CBA). The commonly used modeling methods, including decision trees and Markov models, are compared.

KW - Affordability

KW - Cost-effectiveness

KW - Evaluation

KW - Pharmacoeconomic analysis

U2 - 10.1016/B978-0-12-814276-9.00018-0

DO - 10.1016/B978-0-12-814276-9.00018-0

M3 - Chapter

SN - 9780128142776

SP - 261

EP - 275

BT - Clinical Pharmacy Education, Practice and Research

A2 - Thomas, Dixon

PB - Elsevier

ER -